NCT02906579View on ClinicalTrials.gov

A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 17, 2017

Study Completion Date

March 17, 2017

Conditions
Diabetes Mellitus, Type 2Hypertension
Interventions
DRUG

Matching Placebo

DRUG

IW-1973

Trial Locations (1)

78209

ICON Early Phase Unit, San Antonio

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY

NCT02906579 - A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension | Biotech Hunter | Biotech Hunter